Study of EPN-701 for the Treatment of Calciphylaxis
NCT07583745
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Calciphylaxis
Interventions
DRUG:
EPN-701 (Oral)
DRUG:
Placebo (Normal Saline)
Sponsor
Sagar U. Nigwekar, MD, MMSc